论文信息 - Lp(a) lipoprotein, vascular disease, and mortality in the elderly. - 字舞流文

Lp(a) lipoprotein, vascular disease, and mortality in the elderly.

H. Drexel | C. Saely | T. Marte

[1] A. Scanu. Lp(a) lipoprotein--coping with heterogeneity. , 2003, The New England journal of medicine.

[2] A. Ariyo,et al. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. , 2003, New England Journal of Medicine.

[3] N. Powe,et al. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4] N. Powe,et al. Small Apolipoprotein(a) Size Predicts Mortality in End-Stage Renal Disease: The CHOICE Study , 2002, Circulation.

[5] L. Hervio,et al. The antifibrinolytic effect of lipoprotein(a) in heterozygous subjects is modulated by the relative concentration of each of the apolipoprotein(a) isoforms and their affinity for fibrin , 1996, European journal of clinical investigation.

[6] K. Berg,et al. Changes in Lp(a) lipoprotein and other plasma proteins during acute myocardial infarction , 1994, Clinical genetics.